Mestastop Solutions has raised Rs 4.5 crore or $500k in a pre Series A round led by 92 Angels and Malpani Ventures.
In 2021, the firm had secured a seed funding of Rs 2 crore led by IIM Ahmedabad’s CIIE with participation from IKP and angel investors.
The funds will be used to generate proof of concept data with small molecules around the identified targets and also help progress drug repurposing efforts to delay metastasis by identifying probable clinical candidates. As per the company, new animal models and clinical studies will also be supported, along with strategic business development activities.
Founded by Arnab Roy Chowdhury and Debabani Roy Chowdhury, Mestastop is creating a cancer metastasis focussed platform, which uses wet lab biology and predictive analytics to identify and distinguish unique properties of metastasis and leverage them for drug discovery and patient treatment.